A Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group, Pilot Study to Assess the Efficacy and Safety of H.P. Acthar Gel in Subjects With Relapsing-remitting Multiple Sclerosis
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2019
Price : $35 *
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms OPTIONS
- Sponsors Mallinckrodt Inc.
- 02 Jan 2019 Planned End Date changed from 1 Nov 2018 to 5 Oct 2020.
- 02 Jan 2019 Planned primary completion date changed from 1 Nov 2018 to 27 Feb 2020.
- 22 May 2018 Planned End Date changed from 1 Sep 2018 to 1 Nov 2018.